1-2 of 2
Jia Miao
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Preliminary analysis of a phase 2b, randomized, active-control study of flonoltinib maleate (FM) vs. ruxolitinib in intermediate-2 or high-risk myelofibrosis patients

Free
Lijuan Chen, Na Gao, Wei Yang, Qike Zhang, Hu Zhu, Zhihua Zhang, Lin LIU, Yong Wu, Jinxiao Yao, Zhenfang Liu, Zhenya Hong, Yanping Song, Xiaoyu Zhu, Jia Miao, Jinrong Yang, Ke Tan, Adrian Rui Liang, Zefeng Xu, Ting Niu, Zhijian Xiao
Journal: Blood
Blood (2025) 146 (Supplement 1): 908.
https://doi.org/10.1182/blood-2025-908
Published: 2025
Journal Articles

Phase 1 Safety and Dose Escalation of Purinostat Mesylate, a Uniquely Potent and Selective Inhibitor of HDAC I and IIb in Relapsed or Refractory Lymphoma and Multiple Myeloma

Free
Jie Wang, He Li, Linyu Yang, Ailin Zhao, Peng Zhao, Jishi Wang, Jin Xiang, Jia Miao, Li Zheng, Yongsheng Wang, Lijuan Chen, Ting Niu
Journal: Blood
Blood (2022) 140 (Supplement 1): 6612–6613.
https://doi.org/10.1182/blood-2022-167079
Published: 2022